Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 26,554 | 133,614 | 11,957 | 6,222 | 15,622 |
| Gross Profit | 26,554 | 133,614 | 11,957 | 6,222 | 15,622 |
| Operating Expenses | 31,449 | 47,245 | 22,042 | 23,863 | 29,832 |
| Operating Income | -4,895 | 86,369 | -10,085 | -17,641 | -14,210 |
| Interest Expense | 946 | 1,012 | 1,028 | 1,029 | 725 |
| Other Income | 110 | 9 | 799 | 62 | -554 |
| Pre-tax Income | -5,731 | 85,366 | -10,314 | -18,608 | -15,489 |
| Net Income Continuous | -5,731 | 85,366 | -10,314 | -18,608 | -15,489 |
| Net Income | $-5,731 | $85,366 | $-10,314 | $-18,608 | $-15,489 |
| EPS Basic Total Ops | -1.60 | 23.80 | 10.70 | -6.00 | -5.00 |
| EPS Basic Continuous Ops | -1.56 | 23.86 | 10.75 | -6.02 | -5.03 |
| EPS Diluted Total Ops | -1.60 | 22.80 | 10.70 | -6.00 | -5.00 |
| EPS Diluted Continuous Ops | -1.56 | 22.77 | 10.75 | -6.02 | -5.03 |
| EBITDA(a) | $-3,537 | $87,409 | $-9,424 | $-17,213 | $-13,881 |